Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Omeros Corporation chart...

About the Company

omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.

CEO

Gregory Demopulos

Exchange

NASDAQ

Website

http://www.omeros.com

$54M

Total Revenue

243

Employees

$215M

Market Capitalization

-1.51

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OMER News

OMER Aug 2024 3.000 put

9d ago, source: Yahoo Finance

SEATTLE, February 20, 2024--Omeros Corporation (Nasdaq: OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell ...

Verrica Pharma gains as FDA lists Ycanth in Orange Book

on MSN ago, source:

Verrica Pharmaceuticals (VRCA) receives FDA's NCE status for Ycanth, as FDA lists the antiviral in its Orange Book with five ...

S&P 500 Posts a Record High on Optimism the Fed Can Achieve a Soft Landing

10h ago, source:

Detailed price information for Valero Energy Corp (VLO-N) from The Globe and Mail including charting and trades.

Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade

11d ago, source:

Hidden gems often remain undiscovered within the labyrinth of the stock market. Three stocks with massive upside stand out ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...